C. Vitucci

Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.

G. Colucci, V. Lorusso, P. Foggi, 2009, Anticancer research.

Results of conservative surgery for limited‐sized infiltrating breast cancer: Analysis of 962 tested patients: 24 years of experience

E. Santoro, C. Vitucci, F. Graziano, 2000, Journal of surgical oncology.

Peritoneovenous shunt and neoplastic ascites: A 5‐year experience report

A. Pasqualetti, C. Vitucci, A. Spagnoli, 1986, Journal of surgical oncology.

Potential use of monoclonal antibodies in the diagnostic distinction of gynecomastia from breast carcinoma in men.

M. Mottolese, A. Coli, G. Bigotti, 1991, American journal of clinical pathology.

[Liver metastasis of breast carcinoma. Results of surgical resection. Analysis of 15 operated cases].

M. Carlini, E. Santoro, C. Vitucci, 2000, Chirurgia italiana.

Liver metastases from breast cancer. Results of surgical resection.

R. Santoro, G. Ettorre, M. Carlini, 2002, Hepato-gastroenterology.

Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.

S. Di Cosimo, A. Fabi, P. Carlini, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

P. Foggi, P. Vici, D. Sergi, 2008, Clinica Terapeutica.

Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

M. Mottolese, P. Foggi, P. Perri, 2008, La Clinica terapeutica.